Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01858168 |
Recruitment Status :
Active, not recruiting
First Posted : May 21, 2013
Last Update Posted : March 12, 2024
|
Sponsor:
Massachusetts General Hospital
Information provided by (Responsible Party):
Edwin Choy, MD, Massachusetts General Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | November 2024 |
Estimated Study Completion Date : | December 2024 |